Stocks to Watch: Affymax, MediciNova, AngioDynamics, Tengion

Lakeway, TX -- (SBWIRE) -- 03/11/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Affymax, Inc.(NASDAQ:AFFY) went down 6.53% and closed at $3.29. Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.

How Should Investors Trade AFFY After The Recent Movement? Find Out Here

MediciNova, Inc.(NASDAQ:MNOV) lost 6.71% and closed at $3.20. MediciNova, Inc. is a development-stage biopharmaceutical company focused on acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs with a focus on the United States market.

Is MNOV Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

AngioDynamics, Inc.(NASDAQ:ANGO) went down 12.64% and closed at $10.99. AngioDynamics, Inc. designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Is ANGO a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Tengion, Inc.(PINK:TNGN) moved down 17.78% and closed at $1.11. Develops artificial organs and tissue. The Company develops bioengineered organs and tissues based on experiments on autologous tissue engineering technology and optimal biomaterials. Tengion's technology of creating a neo-organ, such as the Tengion Neo-Bladder, starts when a surgeon sends the patient's biopsy to Tengion.

How Should Investors Trade TNGN After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.